Journal of Cystic Fibrosis 2025

11 papers
The 2025 edition of the Journal of Cystic Fibrosis highlights research on the evolving microbiological landscape and the clinical implications of highly effective modulator therapy (HEMT). A primary focus involves the study of airway infections, including the epidemiology of *Pseudomonas aeruginosa* and the genomic adaptation of *Mycobacterium abscessus*. Research also examines the relationship between chronic inhaled antibiotic use and the emergence of new pathogens, alongside investigations into how specific genetic drivers influence bacterial survival in the post-HEMT lung. Beyond microbiology, the journal explores shifts in clinical management, such as the discontinuation of physiotherapy in adult patients responding well to modulator treatments. Technical developments include the use of resonant acoustic rheometry for non-invasive mucus characterization, while healthcare delivery is addressed through reports on establishing satellite clinics. Notable contributors include Jonathan D. Cogen, Marianne S. Muhlebach, and John J. LiPuma. These studies collectively reflect a transition toward optimizing care and understanding pathogen behavior in an era of advanced cystic fibrosis therapies.

Top Authors

AuthorPapers
Dessi P. Zaharieva1
Dick B.M. Botteldooren1
Hamid Alinejad-Rokny1
N. Jon Shah1
Oliver Biggs Clarke1

Papers

Title
16 Artificial intelligence integrating gut microbiome multi-omics to predict clinical outcomes in children with cystic fibrosis
196 Development of a rapid, non-invasive in situ detection of in vitro mucus characteristics using resonant acoustic rheometry (RAR)
283 Hierarchical protein unfolding at the site of a functional conformational change in human CFTR is the Achilles’ Heel controlling biogenesis efficiency and corrector-drug mechanism
73 Epidemiology of Pseudomonas aeruginosa infection before and after the 2013 Infection Prevention and Control Guidelines
79 Selection scan reveals algG as a putative driver of Pseudomonas aeruginosa survival in the post-ETI lung
853 Establishing a satellite cystic fibrosis clinic: one center’s experience
89 Within-host evolution of transcriptional regulators drives pathogenic adaptation in M. abscessus
AI-facilitated home monitoring for cystic fibrosis exacerbations across pediatric and adult populations
Association between inhaled antibiotic use and treatment-emergent organisms among Canadian people with cystic fibrosis
P182 Physiotherapy discontinuation in adult patients on highly effective modulator therapy
P364 Emergent airway infections with chronic inhaled antibiotics